Fusion Pharmaceuticals (NASDAQ:FUSN) reported its Q4 earnings results on Wednesday, March 20, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Fusion Pharmaceuticals missed estimated earnings by -15.0%, reporting an EPS of $-0.39 versus an estimate of $-0.34.

Revenue was down $140 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.15 which was followed by a 2.0% drop in the share price the next day.

Here's a look at Fusion Pharmaceuticals's past performance:

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Fusion Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.